Form 4: Strata Critical Medical Co-CEO Reports Stock Vesting
Statement of Changes in Beneficial Ownership
Co-CEO and CFO William A. Heyburn acquired 545,625 shares upon performance criteria satisfaction and withheld 301,731 shares for taxes.
Summary
- William A. Heyburn, Co-CEO and CFO of Strata Critical Medical, Inc., reported the vesting of performance-based restricted stock units (PSUs).
- On April 23, 2026, 545,625 shares were acquired following the Compensation Committee's certification of performance criteria.
- On April 24, 2026, 301,731 shares were withheld by the company to satisfy tax obligations related to the vesting.
- Following these transactions, the reporting person holds 1,580,668 shares of Class A common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative event reflecting the fulfillment of pre-existing compensation agreements.
Positives
- The acquisition of shares reflects the successful achievement of performance-based milestones set by the Board of Directors.
Negatives
- The transaction resulted in a significant portion of the vested shares (approximately 55%) being withheld to cover tax liabilities.
Risks
- The reporting person's ownership stake is subject to market volatility and the company's future performance.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this filing.
Management Comments
- The filing notes that the shares were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria.
Industry Context
StockSavvy.ai notes that executive equity vesting events are standard corporate governance procedures and generally do not signal a change in strategic direction, though they highlight the alignment of executive compensation with performance milestones.
Comparison to Industry Standards
- The use of performance-based restricted stock units (PSUs) is a standard industry practice for aligning executive incentives with long-term shareholder value.
- Tax withholding at vesting is a standard administrative procedure for equity compensation plans.
Stakeholder Impact
- Shareholders may view the achievement of performance criteria as a positive indicator of management's success in meeting company goals.
Next Steps
- No future actions or milestones were disclosed in this filing.
Key Dates
| Date | Description |
|---|---|
| 03/20/2025 | Original grant date of the performance-based restricted stock units. |
| 04/23/2026 | Date of acquisition of shares upon certification of performance criteria. |
| 04/24/2026 | Date of share withholding for tax obligations. |
| 04/27/2026 | Date of filing of the Form 4. |
Keywords
Strata Critical Medical, SRTA, Form 4, Insider Trading, Executive Compensation, Performance-based Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.